Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

St. Jude, Boston Scientific ICD Sales Growth Flat-Lines In Q3 – Rebound In ’07?

This article was originally published in The Gray Sheet

Executive Summary

St. Jude Medical is more than halfway through a planned 500-rep expansion of its U.S. implantable cardioverter defibrillator sales force as part of its broader effort to reignite ICD sales growth

You may also be interested in...



Remotely Monitored ICDs Propel Medtronic’s 6% Market Share Gain

Expanding availability and increasing market acceptance of Medtronic's Virtuoso ICD and Concerto cardiac resynchronization therapy product drove a 14% sequential quarterly advance in defibrillator sales, allowing the company to capture market share

Remotely Monitored ICDs Propel Medtronic’s 6% Market Share Gain

Expanding availability and increasing market acceptance of Medtronic's Virtuoso ICD and Concerto cardiac resynchronization therapy product drove a 14% sequential quarterly advance in defibrillator sales, allowing the company to capture market share

Lemonade From Lemons: Boston Scientific CEO On The Changes At Guidant

Boston Scientific's makeover of Guidant is "not rocket science," but "adds up to a major cultural shift" at the recently acquired subsidiary, said Boston Scientific CEO Jim Tobin

Related Content

UsernamePublicRestriction

Register

ID1132679

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel